(RDNT) RadNet - Ratings and Ratios

RadNet, Inc. operates as a leading provider of outpatient diagnostic imaging services, serving patients in the United States and internationally. The company is structured into two primary business segments: Imaging Centers and Digital Health. Through its Imaging Centers segment, RadNet offers a comprehensive range of diagnostic imaging services, including MRI, CT, PET/CT, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and multi-modality imaging. These services are delivered through a network of outpatient facilities designed to provide convenient access to advanced imaging technologies.

In its Digital Health segment, RadNet specializes in the development and deployment of technology solutions for the medical imaging industry. This includes picture archiving and communication systems (PACS), AI-powered health informatics platforms, and DeepHealth OS, a cloud-native operating system designed to optimize radiology operations. The company has also developed AI suites to enhance radiologist interpretation of breast, lung, and prostate imaging, as well as solutions for prostate cancer screening. These innovations aim to improve diagnostic accuracy, streamline workflows, and enhance patient outcomes.

Founded in 1981 and headquartered in Los Angeles, California, RadNet has established itself as a key player in the diagnostic imaging sector, combining clinical expertise with cutting-edge technology to deliver high-quality patient care and advanced informatics solutions. The companys dual focus on imaging services and digital health innovation positions it as a comprehensive provider in the outpatient radiology market.

Ticker Symbol: RDNT
Exchange: NASDAQ
Type: common stock
Country Origin: United States
GICS Sub Industry: Health Care Services
Web URL: https://www.radnet.com